Deciphering the Differential: A Comprehensive Approach to Diagnosing Acute Chest Pain in Clinical Practice

Introduction

Acute chest pain (ACP) represents a diagnostic challenge in clinical practice due to its diverse etiology. Accurate identification of the underlying cause is crucial to initiate appropriate treatment promptly, thereby reducing morbidity and mortality. This article aims to provide a comprehensive approach to diagnosing ACP.

Initial Assessment

The initial evaluation of patients presenting with ACP should include a thorough history, physical examination, and basic investigations such as electrocardiogram (ECG) and cardiac biomarkers. It is essential to identify high-risk features suggestive of life-threatening conditions such as acute coronary syndrome (ACS), pulmonary embolism, or aortic dissection.

Diagnostic Strategies

Several diagnostic strategies can be employed based on the initial assessment. For patients with a high pretest probability of ACS, immediate invasive strategies such as coronary angiography may be warranted. In contrast, patients with an intermediate risk may benefit from non-invasive testing such as stress testing or coronary computed tomography angiography (CCTA). In patients with low-risk features, alternative diagnoses such as gastroesophageal reflux disease or musculoskeletal pain should be considered.

Role of Novel Biomarkers

Novel biomarkers like high-sensitivity troponin and heart-type fatty acid-binding protein (H-FABP) have shown promise in improving the diagnostic accuracy of ACS. These biomarkers can detect myocardial injury earlier than conventional tests, facilitating timely intervention.

Importance of Clinical Judgement

Despite advances in diagnostic modalities, the importance of clinical judgement cannot be overstated. Physicians should integrate the clinical presentation with the results of diagnostic tests to make the most accurate diagnosis.

Conclusion

Diagnosing ACP is a complex process that requires a systematic approach, use of appropriate diagnostic tests, and astute clinical judgement. Continued advancements in diagnostic modalities and biomarkers are expected to further enhance our ability to accurately diagnose and manage patients with ACP.